By Dan Goldstein (dan.goldstein@tueoris.com), Co-founder and Partner, Tueoris, LLC – www.tueoris.com It’s a well-known fact in the life sciences world that data collected today in a clinical trial can have …
By Dan Goldstein, Co-Founder, Tueoris, LLC and Daniela Fábián Masoch, Founder FABIAN PRIVACY LEGAL dan.goldstein@tueoris.com / www.tueoris.com daniela.fabian@privacylegal.ch / www.privacylegal.ch As 2021 begins, ex-EU transfers of personal data continue to …
Since the EU General Data Protection Regulations (“GDPR”) came into effect in 2018, there has been much discussion, but little action, with regard to Article 40 Codes of Conduct (”Codes”) …
For many US-based multinational organizations, EU-approved Standard Contractual Clauses (“SCCs”) have long represented a relatively straightforward solution for the compliant transfer of personal data of EU residents to the organizations’ …
Written by Dan Goldstein, Partner and Co-Founder of Tueoris, LLC In the aftermath of the EU Court of Justice’s Schrems II decision, multinational organizations in the US and around the …
It’s become increasingly clear that true compliance with applicable cookies requirements is no easy task. Sorting through the requirements of General Data Protection Regulation (“GDPR”), the ePrivacy Directive and now …
Organizations subject to global privacy regulations spend what often seems an exorbitant amount of time and resources to reach compliance objectives and keep up with constantly evolving privacy requirements. Data …
Introduction Pharmaceutical and biotech companies sponsoring clinical research have traditionally relied on patient consent as the legal basis for processing personal data, sensitive personal data and biologic material for …